CD30 CAR-T cells have also been evaluated as consolidation following autologous HSCT with BEAM conditioning in a mixed patient population with either Hodgkin lymphoma (HL) or PTCL [98] (NCT02663297). The gene discussed is TNFRSF8; the disease is Hodgkins lymphoma.